The effect of diet on simvastatin and losartan enhancement of endothelial function

Clinical and Experimental Hypertension

Volumn 29, Issue 5, 2007, Pages 311-325

  Bayorh, Mohamed A ^a   Layas, Mohammed F ^a   Mann, Garret ^a   Feuerstein, Giora Z ^b   Eatman, Danita ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cholesterol; Losartan; Nitric oxide; Prostaglandins; SHR; Simvastatin

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; CHOLESTEROL; LOSARTAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; PROSTACYCLIN; SIMVASTATIN; THROMBOXANE A2; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIET; DISEASE COURSE; DRUG EFFECT; DRUG RESPONSE; HYPERTENSION; LIPID DIET; MALE; MONOTHERAPY; NONHUMAN; RAT; SALT INTAKE; SODIUM RESTRICTION; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM;

ALDOSTERONE; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; DIET; DIET, SODIUM-RESTRICTED; DIETARY FATS; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; HEART RATE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; KIDNEY; LIPIDS; LOSARTAN; MALE; NITRIC OXIDE; RATS; RATS, INBRED SHR; SIMVASTATIN; SODIUM, DIETARY; SUPEROXIDES; THROMBOXANE A2;

EID: 34547156745     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960701500463     Document Type: Article

References (32)

1. Negishi H, Njelekela M, Ikeda K, Sagara M, Noguchi T, Kuga S, Kanda T, Liu L, Nara Y, Tagami M, Yamori Y. Assessment of in vivo oxidative stress in hypertensive rats and hypertensive subjects in Tanzania, Africa. Hypertens Res. 2000;23(3):285-289.
2. Bayorh MA, Ganafa AA, Socci RR, Silvestrov N, Abukhalaf IA. The role of oxidative stress in salt-induced hypertension. Am J Hypertens. 2004;17(1):31-36.
3. Jiang J, Roman RJ. Lovastatin prevents development of hypertension in spontaneously hypertensive rats. Hypertension. 1997;30:968-974.
4. O'Donell MP, Kasiske BL, Katz SA, Schmitz PG, Keane WF. Lovastatin but not enalapril reduces glomerural injury in Dahl salt-sensitive rats. Hypertension. 1992;20:651-658.
5. Bayorh M, Ganafa A, Eatman D, Walton M, Feuerstein G. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension. Am J Hypertens. 2005;18(11):1496-1502.
6. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995;332(8):488-493.
7. O'Driscoll G, Green D, Taylor RR. Simvastatin, an HMG-Coenzyme A reductase inhibitor, improves endothelial function within one month. Circulation. 1997;95:1126-1131.
8. Bauersachs J, Galuppo P, Fraccarollo D, Christ M, Ertl G. Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme A reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction. Circulation. 2001;104:982-985.
9. Nahrendorf M, Hu K, Hiller KH, Galuppo P, Fraccarollo D, Schweizer G. Impact of hydroxymethylglutaryl coenzyme A reductase inhibition on left ventricular remodeling after myocardial infarction: an experimental serial cardiac magnetic resonance imaging study. J Am Coll. Cardiol. 2002;40:1695-1700.
10. Lundie MJ, Friberg P, Kline RL, Adams MA. Long-term inhibition of the renin-angiotensin system in genetic hypertension: analysis of the impact on blood pressure and cardiovascular structural changes. J Hypertens. 1997;15(4):339-348.
11. Rizzoni D, Muiesan ML, Porteri E, Castellano M, Zulli R, Bettoni G, Salvetti M, Monteduro C, Agabiti-Rosei E. Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy. J Hypertension. 1997;15(2):197-204.
12. Lefer AM, Scalia R, Lefer DJ. Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease. Cardiovasc Res. 2001;49(2):281-287.
13. Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic : role of nitric oxide. Hypertension. 1998;32:59-64.
14. Zalba G, Beaumont FJ, San José G, Fortuño A, Fortuño MA, Etayo JC, Díez J. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension. 2000;35:1055-1061.
15. Zou AP, Li N, Cowley AW. Production and actions of superoxide in the renal medulla. Hypertension. 2001;37:547-553.
16. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 43:109-142, 1991.
17. Yokota N, O'Donnell M, Daniels F, Burne-Taney M, Keane W, Kasiske B, Rabb H. Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury. Am J Nephrol. 2003;23:13-17.
18. Carneado J, Alvarez de Sotomayor M, Perez-Guerrero C, Jimenez L, Herrera MD, Pamies E, Martin-Sanz MDV, Stiefel P, Miranda M, Bravo L, Marhuenda E. Simvastatin improves endothelial function in spontaneously hypertensive rats through a superoxide dismutase mediated antioxidant effect. J Hypertens. 2002;20(3):429-437.
19. Ikeda U, Shimpo M, Ikeda M, Minota S, Shimada K. Lipophilic statins augment inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. J Cardiovasc Pharm. 2001;38:69-77.
20. Kolyada AY, Fedtsov A, Madias NE. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells. Hypertens. 2001;38:1024-1029.
21. Trochu JN, Mital S, Zhang X, Xu X, Ochoa M, Liao JK, Recchia FA, Hintze TH. Preservation of NO production by statins in the treatment of heart failure. Cardiovasc Res. 2003 Nov 1;60(2):217-219.
22. Takayama T, Wada A, Tsutamoto T, Ohnishi M, Fujii M, Isono T, Horie, M. Contribution of vascular NAD(P)H oxidase to endothelial dysfunction in heart failure and the therapeutic effects of HMG-CoA reductase inhibitor. Circ J. 2004;68:1067-1075.
23. Pérez-Guerrero C, Márquez-Martín A, Herrera, MD, Marhuenda E, Álvarez de Sotomayor M. Regulation of vascular tone from spontaneously hypertensive rats by the HMG-CoA reductase inhibitor, simvastatin. Pharmacology. 2005;74:209-215.
24. 2 synthesis. J Lipid Res. 1985;26:1269-1276.
25. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
26. Nishiyama A, Yoshizumi M, Rahman M, Kobori H, Seth DM, Miyatake A, Zhang GX, Yao L, Hitomi H, Shokoji T, Kiyomoto H, Kimura S, Tamaki T, Kohno M, Abe Y. Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats. Kidney Int. 2004;65:972-981.
27. Tojo A, Onozato ML, Kobayashi N, Goto A, Matsuoka H, Fujita T. Angiotensin II and oxidative stress in Dahl Salt-sensitive rat with heart failure. Hypertens. 2002;40:834-839.
28. Bayorh MA, Ganafa AA, Emmett N, Socci RR, Eatman D, Fridie IL. Alterations in aldosterone and angiotensin II Levels in salt-induced hypertension. Clinical Exp Hypertens. 2005;4:355-367.
29. Iglarz M, Touyz RM, Viel EC, Amiri F, Schiffrin EL. Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction with the renin-angiotensin system. Am J Hypertens. 2004;17:597-603.
30. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II mediated cardiovascular and renal diseases. Pharmacol Rev. 2000;52:11-34.
31. Fujii S, Zhang L, Igarashi J, Kosaka H. L-arginine reverses p47phox and gp91phox expression induced by high salt in Dahl rats. Hypertension. 2003;42:1014-1020.
32. Wassmann S, Laufs U, Bäumer AT, Müller K, Ahlbory K, Linz W, Itter G, Rösen R, Böhm M, Nickenig M. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension. 2001;37:1450-1457.